Suboptimal Weight Loss 13 Years After Roux-en-Y Gastric Bypass Is Associated with Blunted Appetite Response

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Suboptimal Weight Loss 13 Years After Roux-en-Y Gastric Bypass Is Associated with Blunted Appetite Response. / Nymo, Siren; Lundanes, Julianne; Eriksen, Kevin; Aukan, Marthe; Rehfeld, Jens Frederik; Holst, Jens Juul; Johnsen, Gjermund; Græslie, Hallvard; Kulseng, Bård; Sandvik, Jorunn; Martins, Catia.

In: Obesity Surgery, Vol. 34, No. 2, 2024, p. 592-601.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Nymo, S, Lundanes, J, Eriksen, K, Aukan, M, Rehfeld, JF, Holst, JJ, Johnsen, G, Græslie, H, Kulseng, B, Sandvik, J & Martins, C 2024, 'Suboptimal Weight Loss 13 Years After Roux-en-Y Gastric Bypass Is Associated with Blunted Appetite Response', Obesity Surgery, vol. 34, no. 2, pp. 592-601. https://doi.org/10.1007/s11695-023-07028-w

APA

Nymo, S., Lundanes, J., Eriksen, K., Aukan, M., Rehfeld, J. F., Holst, J. J., Johnsen, G., Græslie, H., Kulseng, B., Sandvik, J., & Martins, C. (2024). Suboptimal Weight Loss 13 Years After Roux-en-Y Gastric Bypass Is Associated with Blunted Appetite Response. Obesity Surgery, 34(2), 592-601. https://doi.org/10.1007/s11695-023-07028-w

Vancouver

Nymo S, Lundanes J, Eriksen K, Aukan M, Rehfeld JF, Holst JJ et al. Suboptimal Weight Loss 13 Years After Roux-en-Y Gastric Bypass Is Associated with Blunted Appetite Response. Obesity Surgery. 2024;34(2):592-601. https://doi.org/10.1007/s11695-023-07028-w

Author

Nymo, Siren ; Lundanes, Julianne ; Eriksen, Kevin ; Aukan, Marthe ; Rehfeld, Jens Frederik ; Holst, Jens Juul ; Johnsen, Gjermund ; Græslie, Hallvard ; Kulseng, Bård ; Sandvik, Jorunn ; Martins, Catia. / Suboptimal Weight Loss 13 Years After Roux-en-Y Gastric Bypass Is Associated with Blunted Appetite Response. In: Obesity Surgery. 2024 ; Vol. 34, No. 2. pp. 592-601.

Bibtex

@article{023e51e4ea034bd5a0a2172ae379c6e8,
title = "Suboptimal Weight Loss 13 Years After Roux-en-Y Gastric Bypass Is Associated with Blunted Appetite Response",
abstract = "PURPOSE: Bariatric surgery remains the most efficient treatment to achieve a sustained weight loss. However, a large proportion of patients experience suboptimal weight loss (SWL). The exact mechanisms involved remain to be fully elucidated, but the homeostatic appetite control system seems to be involved. The aim of this study was, therefore, to compare the plasma concentration of gastrointestinal hormones, and appetite ratings, between those experiencing SWL and optimal weight loss (OWL) after Roux-en-Y gastric bypass (RYGB).MATERIALS AND METHODS: Fifty participants from the Bariatric Surgery Observation Study (BAROBS) experiencing either SWL or OWL (< or ≥ 50% of excess weight loss (EWL), respectively) > 13 years post-RYGB were compared to 25 non-surgical controls. Plasma concentrations of acylated ghrelin (AG), total glucagon-like peptide-1 (GLP-1), total peptide YY (PYY), cholecystokinin (CCK), and subjective ratings of hunger, fullness, desire to eat (DTE), and prospective food consumption (PFC) were assessed in the fasting and postprandial (area under the curve (AUC)) states.RESULTS: Those experiencing OWL presented with higher basal AG and GLP-1 iAUC, and lower AG iAUC compared with SWL and controls. Additionally, both bariatric groups presented with higher PYY and CCK iAUC compared to controls. PFC tAUC was also lower in OWL compared to the SWL group. Total weight loss was positively correlated with GLP-1 tAUC and negatively correlated with fasting and tAUC DTE and PFC tAUC.CONCLUSIONS: SWL > 13 years post-RYGB is associated with lower basal ghrelin, as well as a weaker satiety response to a meal. Future studies should investigate the causality of these associations.",
author = "Siren Nymo and Julianne Lundanes and Kevin Eriksen and Marthe Aukan and Rehfeld, {Jens Frederik} and Holst, {Jens Juul} and Gjermund Johnsen and Hallvard Gr{\ae}slie and B{\aa}rd Kulseng and Jorunn Sandvik and Catia Martins",
note = "{\textcopyright} 2023. The Author(s).",
year = "2024",
doi = "10.1007/s11695-023-07028-w",
language = "English",
volume = "34",
pages = "592--601",
journal = "Obesity Surgery",
issn = "0960-8923",
publisher = "Springer",
number = "2",

}

RIS

TY - JOUR

T1 - Suboptimal Weight Loss 13 Years After Roux-en-Y Gastric Bypass Is Associated with Blunted Appetite Response

AU - Nymo, Siren

AU - Lundanes, Julianne

AU - Eriksen, Kevin

AU - Aukan, Marthe

AU - Rehfeld, Jens Frederik

AU - Holst, Jens Juul

AU - Johnsen, Gjermund

AU - Græslie, Hallvard

AU - Kulseng, Bård

AU - Sandvik, Jorunn

AU - Martins, Catia

N1 - © 2023. The Author(s).

PY - 2024

Y1 - 2024

N2 - PURPOSE: Bariatric surgery remains the most efficient treatment to achieve a sustained weight loss. However, a large proportion of patients experience suboptimal weight loss (SWL). The exact mechanisms involved remain to be fully elucidated, but the homeostatic appetite control system seems to be involved. The aim of this study was, therefore, to compare the plasma concentration of gastrointestinal hormones, and appetite ratings, between those experiencing SWL and optimal weight loss (OWL) after Roux-en-Y gastric bypass (RYGB).MATERIALS AND METHODS: Fifty participants from the Bariatric Surgery Observation Study (BAROBS) experiencing either SWL or OWL (< or ≥ 50% of excess weight loss (EWL), respectively) > 13 years post-RYGB were compared to 25 non-surgical controls. Plasma concentrations of acylated ghrelin (AG), total glucagon-like peptide-1 (GLP-1), total peptide YY (PYY), cholecystokinin (CCK), and subjective ratings of hunger, fullness, desire to eat (DTE), and prospective food consumption (PFC) were assessed in the fasting and postprandial (area under the curve (AUC)) states.RESULTS: Those experiencing OWL presented with higher basal AG and GLP-1 iAUC, and lower AG iAUC compared with SWL and controls. Additionally, both bariatric groups presented with higher PYY and CCK iAUC compared to controls. PFC tAUC was also lower in OWL compared to the SWL group. Total weight loss was positively correlated with GLP-1 tAUC and negatively correlated with fasting and tAUC DTE and PFC tAUC.CONCLUSIONS: SWL > 13 years post-RYGB is associated with lower basal ghrelin, as well as a weaker satiety response to a meal. Future studies should investigate the causality of these associations.

AB - PURPOSE: Bariatric surgery remains the most efficient treatment to achieve a sustained weight loss. However, a large proportion of patients experience suboptimal weight loss (SWL). The exact mechanisms involved remain to be fully elucidated, but the homeostatic appetite control system seems to be involved. The aim of this study was, therefore, to compare the plasma concentration of gastrointestinal hormones, and appetite ratings, between those experiencing SWL and optimal weight loss (OWL) after Roux-en-Y gastric bypass (RYGB).MATERIALS AND METHODS: Fifty participants from the Bariatric Surgery Observation Study (BAROBS) experiencing either SWL or OWL (< or ≥ 50% of excess weight loss (EWL), respectively) > 13 years post-RYGB were compared to 25 non-surgical controls. Plasma concentrations of acylated ghrelin (AG), total glucagon-like peptide-1 (GLP-1), total peptide YY (PYY), cholecystokinin (CCK), and subjective ratings of hunger, fullness, desire to eat (DTE), and prospective food consumption (PFC) were assessed in the fasting and postprandial (area under the curve (AUC)) states.RESULTS: Those experiencing OWL presented with higher basal AG and GLP-1 iAUC, and lower AG iAUC compared with SWL and controls. Additionally, both bariatric groups presented with higher PYY and CCK iAUC compared to controls. PFC tAUC was also lower in OWL compared to the SWL group. Total weight loss was positively correlated with GLP-1 tAUC and negatively correlated with fasting and tAUC DTE and PFC tAUC.CONCLUSIONS: SWL > 13 years post-RYGB is associated with lower basal ghrelin, as well as a weaker satiety response to a meal. Future studies should investigate the causality of these associations.

U2 - 10.1007/s11695-023-07028-w

DO - 10.1007/s11695-023-07028-w

M3 - Journal article

C2 - 38159146

VL - 34

SP - 592

EP - 601

JO - Obesity Surgery

JF - Obesity Surgery

SN - 0960-8923

IS - 2

ER -

ID: 378955058